Merck is currently trading at Rs. 1777.10, up by 267.10 points or 17.69% from its previous closing of Rs. 1510.00 on the BSE.
The scrip opened at Rs. 1548.00 and has touched a high and low of Rs. 1812.00 and Rs. 1539.50 respectively. So far 92522 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1812.00 on 19-Apr-2018 and a 52 week low of Rs. 977.00 on 03-Jul-2017.
Last one week high and low of the scrip stood at Rs. 1812.00 and Rs. 1507.10 respectively. The current market cap of the company is Rs. 2944.73 crore.
The promoters holding in the company stood at 51.80%, while Institutions and Non-Institutions held 13.25% and 34.95% respectively.
Merck has signed an agreement to sell its global consumer health business to Procter & Gamble (P&G) for around euro 3.4 billion in cash, or around $4.2 billion at current exchange rates. The transaction, which is expected to close by the end of the fourth quarter 2018, is subject to regulatory approvals and satisfaction of certain other customary closing conditions.
Merck intends to use the net proceeds from the divestiture primarily to accelerate deleveraging. At the same time, it will allow Merck to increase flexibility to strengthen all three business sectors.
Merck is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The company operates through two segments - Pharmaceuticals and Chemicals.
